Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.
Schmader KE; Levin MJ; Gnann JW Jr; McNeil SA; Vesikari T; Betts RF; Keay S; Stek JE; Bundick ND; Su SC; Zhao Y; Li X; Chan IS; Annunziato PW; Parrino J; Clinical Infectious Diseases: An Official Publication Of The Infectious Diseases Society Of America, 2012, vol. 54, issue 7, p 922, ISSN 15376591. ISBN 15376591.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef